Cargando…
How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?
Mesenchymal stem cell (MSC) is an intensely studied stem cell type applied for cardiac repair. For decades, the preclinical researches on animal model and clinical trials have suggested that MSC transplantation exerts therapeutic effect on ischemic heart disease. However, there remain major limitati...
Autores principales: | Li, Liangpeng, Chen, Xiongwen, Wang, Wei Eric, Zeng, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670674/ https://www.ncbi.nlm.nih.gov/pubmed/26681958 http://dx.doi.org/10.1155/2016/9682757 |
Ejemplares similares
-
Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction
por: Yue, Rongchuan, et al.
Publicado: (2017) -
Correction: Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction
por: Yue, Rongchuan, et al.
Publicado: (2022) -
Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
por: Chen, Zhi, et al.
Publicado: (2018) -
Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke
por: Wang, Fan, et al.
Publicado: (2018) -
Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats
por: Liu, Xian-Bao, et al.
Publicado: (2014)